ImStem Biotechnology Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 15
Employees
  • Latest Deal Type
  • Debt
  • Investors
  • 3

ImStem Biotechnology General Information

Description

Developer of a stem cell technology designed to remodel health and lifespan. The company's technology is derived from mesenchymal stem cells that have a strong anti-inflammatory activity and offers a wide range of treatments for a variety of diseases caused by damage to cells, tissues and organs, enabling doctors to focus on tissue repair, treatment of neural, heart, vascular, blood system diseases and autoimmune diseases.

Contact Information

Website
www.imstem.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 400 Farmington Avenue R1808
  • Call Box 111
  • Farmington, CT 06032
  • United States
+1 (860) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ImStem Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Debt - General 07-Nov-2013 00000 Completed Clinical Trials - General
2. Seed Round 10-Oct-2013 00000 00000 Completed Clinical Trials - General
1. Grant 10-Jun-2013 $1.13M Completed Clinical Trials - General
To view ImStem Biotechnology’s complete valuation and funding history, request access »

ImStem Biotechnology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a stem cell technology designed to remodel health and lifespan. The company's technology is derived from me
Drug Discovery
Farmington, CT
15 As of 2021
00000
000000000 00000

000 0000

ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et do
0000 000000000
Barcelona, Spain
00 As of 0000
0000
00000000000 0000

00000000

et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut
0000 000000000
New York, NY
00 As of 0000
0000
00.00 0000-00-00
00000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ImStem Biotechnology Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ona Therapeutics Venture Capital-Backed Barcelona, Spain 00 0000 00000000000 0000
00000000 Venture Capital-Backed New York, NY 00 0000 00000000000 0000
0000000 Venture Capital-Backed Solna, Sweden 0 00.000 0000000000 00.000
00 000000000000 Formerly VC-backed Durham, NC 000 00000 000000 - 000 00000
0000000 000000 Venture Capital-Backed Barcelona, Spain 00 0000 000000000000 0000
You’re viewing 5 of 7 competitors. Get the full list »

ImStem Biotechnology Patents

  • 6

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

ImStem Biotechnology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-9745551-B2 Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof Active 12-Jul-2012 0000000000 0
US-20150203820-A1 Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof Granted 12-Jul-2012 0000000000 0
US-10557122-B2 Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof Active 12-Jul-2012 0000000000
US-20180010098-A1 Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof Granted 12-Jul-2012 0000000000 0
US-20200392463-A1 Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof Pending 12-Jul-2012 C12N5/0662

ImStem Biotechnology Executive Team (4)

Name Title Board Seat Contact Info
Michael Men MD Co-Founder, Chief Executive Officer, President & Board Member
Xiaofang Wang Ph.D Co-Founder, Chief Technology Officer, Vice President and Board Member
Richard Kim MD Chief Medical Officer
You’re viewing 3 of 4 executive team members. Get the full list »

ImStem Biotechnology Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ImStem Biotechnology Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
CaroGen VC-Backed Company Minority 000 0000 000000 0
Connecticut Innovations Venture Capital Minority 000 0000 000000 0
Connecticut Stem Cell Research Program Other 000 0000 000000 0
To view ImStem Biotechnology’s complete investors history, request access »

Ready to get started?

Request a free trial